Delving into the Latest Updates on Spinal Restoration, Inc. with Synapse

概览

关联

2

项与 Spinal Restoration, Inc. 相关的临床试验

NCT01011816 / Terminated临床3期

A Multicenter, Randomized, Blinded, Saline-Controlled Trial of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System

The purpose of this investigation is to establish the safety and efficacy of the Biostat System when used for treatment of chronic low back (lumbar) pain due to symptomatic internal disc disruptions (IDD) by comparing safety and efficacy outcome measures between one group receiving BIOSTAT BIOLOGX® Fibrin Sealant through the Biostat® Delivery Device and another group receiving a preservative-free normal saline control delivered with the Biostat Delivery Device.

开始日期2010-03-01

申办/合作机构

Spinal Restoration, Inc.

NCT00693784 / CompletedN/A

A Multicenter Pilot Study of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® Disc Augmentation System

The purpose of this study is to assess the safety of the Biostat Disc Augmentation System for the treatment of chronic low-back (lumbar) pain due to symptomatic internal disc disruptions (IDD) and to obtain preliminary efficacy information.

开始日期2008-06-01

申办/合作机构

Spinal Restoration, Inc.

100 项与 Spinal Restoration, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Spinal Restoration, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Spinal Restoration, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Spinal Restoration, Inc. 相关的转化医学

登录后查看更多信息